Sedative and Hypnotic Interactions Between Sevoflurane and Etomidate
张凌,张马忠,宋蕴安,王珊娟,杭燕南
DOI: https://doi.org/10.3760/cma.j.issn.0254-1416.2009.05.001
2009-01-01
Abstract:Objective To evaluate sedative and hypnotic interactions between sevoflurane and etomidate. Methods Twenty-four ASA Ⅰ or Ⅱ patients aged 18-59 yr with body mass index 17-27 kg/m2 undergoing elective surgery under general anesthesia were included in this study. Part Ⅰ Twelve patients received etemidate by TCI at target effect-site concentrations (Ce) of 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5 μg/ml in turn. When the preset concentrations were reached for 2 min, the spectral entropy index (response entropy, RE; state entropy, SE) and Observer's Assessment of Alertuess/Sedation (OAA/S) score were recorded and TCI of etomidate was stopped. The patients were randomly divided into 3 groups ( n = 4 each), inhaling sevoflurane with end-tidal concentrations of 0.5% (group A1 ), 1% (group B1 ) and 2% (group C1 ). When the sevoflurane concentration reached 95% predetermined end-tidal concentration or more, etomidate was administered via TCI at Ce of 0.05, 0.1, 0.2, 0.3, 0.4 and 0.5 μg/ml in turn. When the preset concentrations were reached for 2 min, RE, SE and OAA/S score were recorded. Part Ⅱ Twelve patients inhaled sevoflurane with end-tidal concentrations of 0.5%, 1%, 2%, 3%, 4% and 5% in turn. When the predetermined end-tidal concentrations were reached, RE, SE and OAA/S score were recorded and inhalation of sevoflurane was stopped. Sevoflurane was washed out. Then the patients were randomly divided into 3 groups ( n = 4 each), receiving etomidate by TCI at Ce of 0.05 μg/ml (group A2), 0.1 μg/ml ( group B2) and 0.2 μg/ml ( group C2) respectively. The patients inhaled sevoflurane with end-tidal concentrations of 0.5%, 1%, 2%, 3%, 4% and 5% in turn 2 min after the preset concentrations were reached. When the predetermined end-tidal concentrations were reached, RE, SE and OAA/S score were recorded. Response surface pharmacodynamic interaction models were constructed to evaluate RE, SE and OAA/S score and determine sedative and hypnotic interactions between sevoflurane and etomidate. Results The fitted values of the interaction index a of RE and SE (95% confidence intervals, 95% CI) were 0.32 ( - 0.07-0.71 ) and 0.25 (-0.12-0.63) respectively (P > 0.05). The fitted value of the interaction index a of OAA/S score (95% CI) was 2.25 (0.58-3.93) (P <0.05).Conclusion The interaction between etomidate and sevoflurane is additive and synergistic for sedation and hypnosis assessed by spectral entropy index and by OAA/S score respectively.